Company: EUDAW
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001641172-25-006627
Chunk: 2

Company: EUDA Health Holdings Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 3
Chunk 2
---
’s stem cell services in
Singapore or Malaysia. This collaboration agreement is terminable by either party with one month’s notice of termination. If Key
Lock loses its rights to distribute services for Guangdong Cell Biotech, it is very likely that EUDA will also lose its rights to distribute
Guangdong Cell Biotech’s stem cell therapies in Singapore and Malaysia.

A significant shareholder
of the Company holds demand registration rights for a significant number of ordinary shares and the resale of these shares could cause
a significant decline on the trading price of the Company’s ordinary shares.

In connection with the
acquisition of CK Health, the Company issued to the former shareholders of Fortress Cove Limited an aggregate of 8,571,428 ordinary
shares, 40% of which were issued to Mr. Meng Dong (James) Tan who holds approximately 25% of the currently issued and outstanding
ordinary shares of the Company. Mr. Meng Dong (James) Tan also has the right to demand the Company at any time in his sole direction
to file a registration statement with the SEC for the resale of any or all of these 8,571,428 ordinary shares. The resale of these
shares could cause a significant decline on the trading price of the Company’s ordinary shares.

The Company has a new
Chief Operating Officer, a part-time Interim Chief Financial Officer and management team has limited experience of working together.

Effective
April 21, 2025, Mr. John Ang joined EUDA as its Chief Operating Officer. Effective September 3, 2024, Ms. Vivian Tay served as the Company’s
part-time Interim Chief Financial Officer while the Company searches for a full-time successor CFO. The Company’s management team
is currently comprised of Mr. Alfred Lim, the Chief Executive Officer and Executive Director, Mr. John Ang, the Chief Operating Officer,
and Ms. Vivian Tay, the Interim Chief Financial Officer. The Company’s management team have limited experience of working together,
managing a publicly traded company, interacting with public company investors, and complying with the increasingly complex laws, rules
and regulations that govern U. S. public company. Loss of any one of them would likely harm the Company’s ability to implement its
business strategy and respond to the rapidly changing market conditions in which it operates. The Company cannot assure you that management
will succeed in working together as a team. In the event that the Company is unable to retain or integrate its management team, its business,
prospects, and